Chemotactic peptide receptor modulation in polymorphonuclear leukocytes

Journal of Cell Biology

Volumn 85, Issue 3, 1980, Pages 703-711

  Sullivan, Susan J ^a   Zigmund, Sally H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DEOXYGLUCOSE; DRUG RECEPTOR; PEPTIDE; RADIOISOTOPE;

ANIMAL EXPERIMENT; BLOOD AND HEMOPOIETIC SYSTEM; CARBOBENZOXYPHENYLALANYLMETHIONINE; CHEMOTAXIS; IN VITRO STUDY; N FORMYLNORLEUCYLLEUCYLPHENYLALANINE H 3; NEUTROPHIL; RABBIT;

ADAPTATION, PHYSIOLOGICAL; ANIMAL; BIOLOGICAL TRANSPORT; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; DOSE-RESPONSE RELATIONSHIP, DRUG; NEUTROPHILS; RABBITS; RECEPTORS, DRUG;

EID: 0019307854     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.85.3.703     Document Type: Article

References (38)

1. Aswanikumar, S., B. Corcoran, E. Schiffmann, A. R. Day, R. J. Freer, H. J. Showell, E. L. Becker, and C. B. Pert. 1977. Demonstration of a receptor on rabbit neutrophils for chemotactic peptides. Biochem. Biophys. Res. Commun. 74: 810-817.
2. Brown, M. S., and J. L. Goldstein. 1979. Receptor mediated endocytosis: Insights from the lipoprotein receptor system. Proc. Natl. Acad Set. U. S. A. 76: 3330-3337.
3. Boucek, M. M., and R. Snyderman. 1976. Calcium influx requirement for human neutrophil chemotaxis: Inhibition by lanthanum chloride. Science (Wash. D. C.). 193: 905-907.
4. 125I-labeled human epidermal growth factor. Binding, internalization and degradation in human fibroblasts. J. Cell Biol. 71: 159-171.
5. Catt, K. J., J. P. Harwood, G. Aguilera, and M. L. Dufau. 1979. Hormonal regulation of peptide receptors and target cell responses. Nature (Lond.) 280: 109-116.
6. Conn, P. M., M. Conte, J. P. Harwood, M. L. Dufau, and K. J. Catt. 1978. Internalization of gonadotrophin-receptor complex in ovarian luteal cells. Nature (Lond.) 274: 598-560.
7. Craddock, P. R., D. Hammerschmidt, J. G. White, A. P. Dalmasso, and H. S. Jacob. 1977. Complement (C 5a)-induced granulocyte aggregation in vitro. J. Clin. Invest. 60: 260-264.
8. Das, M., T. Miyakawa, C. F. Fox, R. M. Pruss, A. Aharonov, and H. R. Herschman. 1977. Specific radiolabelling of a cell surface receptor for epidermal growth factor. Proc. Natl. Acad. Sci. V. S. A. 74: 2790-2794.
9. Farquhar, M. G. 1978. Recovery of surface membrane in anterior pituitary cells. J. Cell Biol. 77: R35-R42.
10. Goldstein, J. L., R. G. W. Anderson, and M. S. Brown. 1979. Coated pits, coated vesicles and receptor mediated endocytosis. Nature (Lond.) 279: 679-685.
11. Hinkle, P. M., and A. H. Tashjian, Jr. 1975. Thyrotrophin releasing hormone regulates the number of its own receptors in the GH.i strain of pituitary cells in culture. Biochemistry 14: 3845-3851.
12. Hsueh, A. J. W., M. L. Dufau, and K. J. Catt. 1977. Gonadotrophin induced regulation of luteinizing hormone receptors and desensitization of testicular 3′: 5′ cyclic AMP and testosterone responses. Proc. Natl. Acad. Sci. U. S. A. 74: 592-595.
13. Keller, H. U., and E. Sorkin. 1966. Studies on chemotaxis. IV. The influence of serum factors on granulocyte locomotion. Immunology. 10: 409-416.
14. Keller, H. U., and E. Sorkin. 1967. Studies on chemotaxis. V. On the chemotactic effect of bacteria. Int. Arch. Allergy Appl. Immunol. 31: 505-517.
15. Klein, C., and M. H. Juliana. 1977. cAMP-induced changes in cAMPbinding sites on D. discoideum amebae. Cell. 10: 329-335.
16. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275.
17. Lefkowitz, R. S., D. Mullkin, and L. T. Williams. 1978. A desensitized state of the beta adrenergic receptor not associated with high affinity agonist occupancy. Mol. Pharmacol. 14: 376-380.
18. Naccache, P. H., H. J. Showell, E. L. Becker, and R. I. Sha’afi. 1977. Transport of sodium, potassium and calcium across rabbit polymorphonuclear leukocyte membranes, effect of chemotactic factor. J. Cell Biol. 73: 428-444.
19. Niedel, J., I. Kahane, and P. Cuatrecasas. 1979. Receptor mediated internalization of fluorescent chemotactic peptide by human neutrophils. Science (Wash. D. C.). 205: 1412-1414.
20. O’Flaherty, J. T., D. L. Kreutzer, H. J. Showell, G. Vitkauskas, E. L. Becker, and P. A. Ward. 1979. Selective neutrophil desensitization to chemotactic factors. J. Cell Biol. 80: 564-572.
21. O’Flaherty, J. T., H. J. Showell, D. L. Kreutzer, P. A. Ward, and E. L. Becker. 1978. Inhibition of in vivo and in vitro neutrophil responses to chemotactic factors by a competitive antagonist. J. Immunol. 120: 1326-1332.
22. 3H) formyl-Norleu-Leu-Phe to plasma membrane of rabbit neutrophils. FEBS (Fed. Eur. Biochem. Soc.) Lett. 91: 305-309.
23. Schiffmann, E., B. A. Corcoran, and S. M. Wahl. 1975. N-formylmethionyl peptides are chemotactic for leukocytes. Proc. Natl. Acad. Sci. U S A. 72: 1059-1062.
24. Schonbrunn, A., and A. H. Tashjian, Jr. 1978. Characterization of functional receptors for somatostatin in rat pituitary cells in culture. J. Biol. Chem. 253: 6473-6483.
25. Shin, H. S., R. Snyderman, E. Friedman, A. Mellors, and M. M. Mayer. 1968. Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science (Wash. D. C.). 162: 361-363.
26. Showell, H. J., R. J. Freer, S. H. Zigmond, E. Schiffmann, A. Srivinivesaldratt, B. Corcoran, and E. L. Becker. 1976. The structure activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils. J. Exp. Med. 143: 1154-1169.
27. Spilberg, I., and J. Mehta. 1979. J. Clin. Invest. 63: 85-88.
28. Su, Y., T. K. Harden, and J. P. Perkins. 1979. Isopreterenol-induced desensitization of adenylate cyclase in human astrocytoma cells. J. Biol. Chem. 254: 38-41.
29. Turner, S. R., J. A. Campbell, and W. S. Lynn. 1975. Polymorphonuclear leukocyte chemotaxis toward oxidized lipid components of cell membranes. J. Exp. Med. 141: 1437-1441.
30. Ward, P. A., and E. L. Becker. 1968. The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase. J. Exp. Med. 127: 693-709.
31. Ward, P. A., and L. J. Newman. 1969. A neutrophil chemotactic factor from C’5. Immunology. 102: 93-99.
32. Ward, P. A., H. G. Remold, and J. R. David. 1970. The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor. Cell. Immunol. 1: 162-174.
33. Wessels, M. R., D. Mullkin, and R. J. Lefkowitz. 1978. Differences between agaonist and antagonist binding following B-adrenergic receptor desensitization. J. Biol. Chem. 253: 3371-3373.
34. Wilkinson, P. C., and I. C. McKay. 1972. The molecular requirements for chemotactic attraction of leukocytes by proteins. Studies of proteins with synthetic side groups. Eur. J. Immunol. 2: 570-577.
35. Williams, L. T., and R. J. Lefkowitz. 1977. Slowly reversible binding of catecholamine to a nucleotide-sensitive state of the B-adrenergic receptor. J. Biol. Chem. 252: 7207-7213.
36. Williams, L. T., R. Snyderman, M, C. Pike, and R. J. Lefkowitz. 1977. Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. U. S. A. 74: 1204-1208.
37. Zigmond, S. H. 1977. The ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. J. Cell Biol. 75: 606-616.
38. Zigmond, S. H., and S. J. Sullivan. 1979. Sensory adaptation of leukocytes to chemotactic peptides. J. Cell Biol. 82: 517-527.